NCT03819140 2025-11-14
CCOUP
University of California, San Francisco
Phase 4 Completed
Clinical Trials
63 trialsNCT04874415 2025-10-28
Behavioral Economics for Activity Motivation in Adolescents (BEAM)
University of Pittsburgh
Phase NA Completed
NCT05370521 2025-10-09
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
Spruce Biosciences
Phase 2 Terminated
NCT02500147 2025-07-02
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
Columbia University
Phase 4 Terminated
NCT03229408 2025-06-10
TIN-PCOS-AOD
University of Illinois at Chicago
Phase 2 Completed
NCT05206448 2025-04-15
CLC II
University of Iowa
Phase 4 Active not recruiting
NCT03717935 2025-03-24
ORANGE
University of Colorado, Denver
Phase NA Completed
NCT01785719 2025-02-03
Evaluation of Ovarian Morphology and Function in Overweight Women During Weight Loss
Cornell University
Phase NA Completed
NCT01889199 2025-01-10
Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women
University of California, Los Angeles
Phase 2 Completed
NCT00696111 2024-12-31
Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea
University of Chicago
Phase NA Completed
NCT00427700 2024-08-21
Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
Hospital de Clinicas de Porto Alegre
Phase 3 Completed
NCT02157974 2024-06-04
APPLE
University of Colorado, Denver
Phase 2/3 Completed
NCT04942366 2024-02-02
High-Intensity Interval Training On Women With Polycystic Ovary Syndrome.
Ziauddin University
Phase NA Completed
NCT00203996 2023-03-21
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
University of Chicago
Phase 4 Terminated
NCT03987854 2022-10-25
The University of Michigan PCOS Intervention Using Nutritional Ketosis
University of Michigan
Phase 1/2 Completed
NCT03951077 2022-06-08
Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome
AbbVie
Phase 2 Completed
NCT01482286 2022-03-15
PULSE
Pennington Biomedical Research Center
Phase 3 Terminated
NCT04006171 2021-11-05
CNP
Near East University, Turkey
Phase NA Completed
NCT00743574 2021-08-13
Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)
Yale University
Phase NA Completed
NCT03480022 2021-06-07
SAXAPCOS
Woman's
Phase 3 Completed
NCT02865915 2021-02-01
MLE4901 vs. Placebo for the Treatment of PCOS
Millendo Therapeutics, Inc.
Phase 2 Terminated
NCT02635386 2021-01-29
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Woman's
Phase 3 Completed
NCT03152591 2021-01-05
PCOS
Novartis
Phase 2 Completed
NCT01428245 2020-12-30
JCM026
University of Virginia
Phase NA Terminated
NCT01718444 2020-09-29
Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)
University of Illinois at Chicago
Phase NA Terminated
NCT01672801 2020-08-11
NIMO
Boston IVF
Phase NA Completed
NCT02122380 2020-05-08
The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
Vanderbilt University Medical Center
Phase 4 Completed
NCT03117517 2020-03-02
Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome
Khyber Medical University Peshawar
Phase EARLY_PHASE1 Completed
NCT03644212 2020-01-13
Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS
Maimonides Medical Center
Phase 4 Completed
NCT02145247 2019-08-12
Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)
University of California, San Diego
Phase NA Completed
NCT02073929 2019-02-28
LIPT
Herlev Hospital
Phase 4 Completed
NCT00747617 2018-11-21
Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)
University of California, San Diego
Phase 3 Completed
NCT01815138 2018-10-26
Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS
UConn Health
Phase 4 Completed
NCT02460380 2018-10-12
The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome
Maimonides Medical Center
Phase 4 Completed
NCT01607320 2018-09-20
PCOS
Prisma Health-Upstate
Phase NA Terminated
NCT00805207 2018-08-01
SCOR
Washington University School of Medicine
Phase NA Completed
NCT00989781 2018-06-04
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
University of California, San Diego
Phase NA Completed
NCT01428193 2018-06-04
Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
University of Virginia
Phase NA Terminated
NCT00151411 2018-03-21
Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)
Milton S. Hershey Medical Center
Phase 2 Completed
NCT00907153 2017-12-19
Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)
Milton S. Hershey Medical Center
Phase 1/2 Completed
NCT00640224 2017-11-17
Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
University of Pittsburgh
Phase 4 Completed
NCT01483118 2017-10-03
Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS)
Columbia University
Phase 3 Completed
NCT00703508 2017-06-14
Pharmacogenetics of Metformin Action in PCOS
Virginia Commonwealth University
Phase NA Completed
NCT01360996 2017-03-31
BEYAZ-PCOS
Woman's
Phase 4 Completed
NCT00704912 2016-11-07
OWL-PCOS
Milton S. Hershey Medical Center
Phase 2 Completed
NCT02328404 2016-08-04
The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)
Hayat Pharmaceutical Co. PLC
Phase 3 Completed
NCT00868140 2016-06-10
PCOS
Virginia Commonwealth University
Phase NA Terminated
NCT02498522 2016-05-19
MIP
Ain Shams University
Phase EARLY_PHASE1 Completed
NCT02389088 2016-03-10
Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH.
University of California, San Diego
Phase NA Completed
NCT01653743 2016-01-07
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed